Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 17, 2006Liver Transplantation

Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

YTYasutsugu TakadaYamato Municipal HospitalMUMikiko UedaMinistry of Education, Culture, Sports, Science and TechnologyTITakashi ItoUniversity of Nagasaki

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Takada et al. (2006) studied this question.

synapsesocial.com/papers/6a7db660c2b228f3e18c9bcdhttps://doi.org/10.1002/lt.20642
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Survival and Recurrence After Liver Transplantation Versus Liver Resection for Hepatocellular Carcinoma1998 · 226 citations
  2. 2Impact of Right Lobe with Middle Hepatic Vein Graft in Living-Donor Liver Transplantation2005 · 98 citations
  3. 3Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation12002 · 151 citations
  4. 4Liver Transplantation for Hepatocellular Carcinoma2008 · 316 citations
  5. 5Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis1996 · 7,229 citations